Earlier this month, I wrote here about the flowering of Israel’s innovative biotechnology sector over the past ten years following adoption of important […]
Biotechnology in Countries Starting with “I” – Part 14: India Read Post »
Here’s a copy of the talk I gave at the American Chemical Society meeting, on using patent information to track
A new report from DrugPatentWatch.com profiles the leading researchers, US states, and countries responsible for drugs approved over the past
This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’
Patent Analysis: A Tool for Making Strategic Business Decisions Read Post »
This is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so,
India, Intellectual Property and Biotechnology Industry Read Post »
With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that
Biologic data exclusivity: The arguments for and against it Read Post »
This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’
In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products
In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products
I’ll be giving a talk at the Kogod School of Business on Tuesday February 24th on “Drug Development – Balancing
Drug Development – Balancing National and Commercial Needs Read Post »